« Back to Record
Citation APA

Salgado, R., Denkert, C., Campbell, C., Savas, P., Nucifero, P., Aura, C. M., de Azambuja, E., Eidtmann, H., Ellis, C., Baselga, J., Piccart-Gebhart, M., Michiels, S., Bradbury, I., Sotiriou, C., & Loi, S. (2015). Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial. JAMA oncology, 1(4), 448-454. doi:10.1001/jamaoncol.2015.0830


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/220013

Salgado, R., Denkert, C., Campbell, C., Savas, P., Nucifero, P., Aura, C. M., de Azambuja, E., Eidtmann, H., Ellis, C., Baselga, J., Piccart-Gebhart, M., Michiels, S., Bradbury, I., Sotiriou, C., & Loi, S. (2015). Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial. JAMA oncology, 1(4), 448-454. doi:10.1001/jamaoncol.2015.0830